KMT2C and breast carcinoma: In breast cancer, Zheng et al. identified an enhancer associated with MLL3, and MLL3 deletion promoted cell migration and resulted in reduced activity of an enhancer approximately 7 kb upstream of TNS3, and further inhibition of this enhancer activity by the dCas9 KRAB system decreased expression of the target gene TNS3 [54].